» Articles » PMID: 36531716

A Comparative Study of Antihypertensive Drugs Prediction Models for the Elderly Based on Machine Learning Algorithms

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Globally, blood pressure management strategies were ineffective, and a low percentage of patients receiving hypertension treatment had their blood pressure controlled. In this study, we aimed to build a medication prediction model by correlating patient attributes with medications to help physicians quickly and rationally match appropriate medications.

Methods: We collected clinical data from elderly hypertensive patients during hospitalization and combined statistical methods and machine learning (ML) algorithms to filter out typical indicators. We constructed five ML models to evaluate all datasets using 5-fold cross-validation. Include random forest (RF), support vector machine (SVM), light gradient boosting machine (LightGBM), artificial neural network (ANN), and naive Bayes (NB) models. And the performance of the models was evaluated using the micro-F1 score.

Results: Our experiments showed that by statistical methods and ML algorithms for feature selection, we finally selected Age, SBP, DBP, Lymph, RBC, HCT, MCHC, PLT, AST, TBIL, Cr, UA, Urea, K, Na, Ga, TP, GLU, TC, TG, γ-GT, Gender, HTN CAD, and RI as feature metrics of the models. LightGBM had the best prediction performance with the micro-F1 of 78.45%, which was higher than the other four models.

Conclusion: LightGBM model has good results in predicting antihypertensive medication regimens, and the model can be beneficial in improving the personalization of hypertension treatment.

Citing Articles

Antihypertensive Drug Recommendations for Reducing Arterial Stiffness in Patients With Hypertension: Machine Learning-Based Multicohort (RIGIPREV) Study.

Cavero-Redondo I, Martinez-Rodrigo A, Saz-Lara A, Moreno-Herraiz N, Casado-Vicente V, Gomez-Sanchez L J Med Internet Res. 2024; 26:e54357.

PMID: 39585738 PMC: 11629035. DOI: 10.2196/54357.


A Real-World Study on the Short-Term Efficacy of Amlodipine in Treating Hypertension Among Inpatients.

Wang T, Tan J, Wang T, Xiang S, Zhang Y, Jian C Pragmat Obs Res. 2024; 15:121-137.

PMID: 39130528 PMC: 11316486. DOI: 10.2147/POR.S464439.


Transforming Healthcare: The AI Revolution in the Comprehensive Care of Hypertension.

Alam S, Gonzalez Suarez M Clin Pract. 2024; 14(4):1357-1374.

PMID: 39051303 PMC: 11270379. DOI: 10.3390/clinpract14040109.

References
1.
Wang M, Li N, Luo Q, Wang G, Heizhati M, Wang L . Development and validation of a novel diagnostic nomogram model to predict primary aldosteronism in patients with hypertension. Endocrine. 2021; 73(3):682-692. DOI: 10.1007/s12020-021-02745-7. View

2.
Ball R, Robb M, Anderson S, Dal Pan G . The FDA's sentinel initiative--A comprehensive approach to medical product surveillance. Clin Pharmacol Ther. 2015; 99(3):265-8. DOI: 10.1002/cpt.320. View

3.
Liu C, Xu J, Liu R, Wang M, Zhuo Y, Su L . Identifying drug-related attributes to personalise antihypertensive agents: the outcome report of patients receiving metoprolol therapy. BMC Med Inform Decis Mak. 2021; 21(1):370. PMC: 8717677. DOI: 10.1186/s12911-021-01739-9. View

4.
Stamler J, Chan Q, Daviglus M, Dyer A, Van Horn L, Garside D . Relation of Dietary Sodium (Salt) to Blood Pressure and Its Possible Modulation by Other Dietary Factors: The INTERMAP Study. Hypertension. 2018; 71(4):631-637. PMC: 5843536. DOI: 10.1161/HYPERTENSIONAHA.117.09928. View

5.
Jernberg T, Attebring M, Hambraeus K, Ivert T, James S, Jeppsson A . The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010; 96(20):1617-21. DOI: 10.1136/hrt.2010.198804. View